National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

This is VAERS ID 1859474

Government Disclaimer on use of this data



Case Details

VAERS ID: 1859474 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-11-03
Onset:2021-11-04
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-11-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Exposure during pregnancy, Eye swelling, Incorrect route of product administration
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Drug abuse and dependence (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Hypersensitivity (narrow), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Pregnancy (The due date for the baby is 18-Apr-2022)
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBSA2021SA368621

Write-up: Eye swelling; Initial information regarding this unsolicited valid serious case received from Health Authorities from consumer (reference number-GB-MHRA-EYC 00265349) was transmitted to Sanofi on 07-Nov-2021. This case involved a 39 years old female patient (162 cm and 80 kg) who developed eye swelling while receiving INFLUENZA VACCINE and DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE (DTPA IPV VACCINE) The patient''s medical history, past medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Pregnancy with the due date for the baby would be 18-Apr-2022. On 03-Nov-2021, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot Unknown via parenteral route in unknown administration site for Prophylactic vaccination and DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE (DTPA IPV VACCINE) produced by unknown manufacturer lot Unknown via parenteral route in unknown administration site for Prophylactic vaccination. On 04-Nov-2021 the patient developed a serious event eye swelling 1 day following the administration of INFLUENZA VACCINE and DTPA IPV VACCINE. This event was assessed as medically significant as per reporter. No relevant laboratory data was reported. It was not reported if the patient received a corrective treatment for the event (Eye swelling). At time of reporting, the outcome was Not Recovered for the event. No further relevant information was provided.; Sender''s Comments: This case involved a 39 year old female patient who had eye swelling after vaccination with INFLUENZA VACCINE and DTPA IPV VACCINE (produced by unknown manufacture).The time to onset is compatible. However, information on patient''s health condition at the time of vaccination, past medication ,relevant medical history, concomitants, and other relevant laboratory data was not provided. Based upon the reported information, the role of an individual suspect vaccine cannot be assessed.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1859474


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166